Mutations in the two known BRCA genes account for only 5% to 10% of br
east cancer, The genes may play a role in genomic stability; their rol
e in sporadic cancer remains unknown, Hence, genetic testing has creat
ed clinical dilemmas, Some pertain to women whose family history sugge
sts inherited risk. Others, including the false reassurance that may b
e conferred by a negative finding, apply throughout the general popula
tion.